We provide you with 20 years of free, institutional-grade data for ADMA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ADMA. Explore the full financial landscape of ADMA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$1,283,223
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
Grossman Adam S | Sale | -21,000 | $16.13 | $338,730 | 2025-09-16 |
Grossman Adam S | Derivatives Exercise | 15,000 | 2025-09-16 | ||
Grossman Adam S | Sale | -21,000 | $16.88 | $354,480 | 2025-08-15 |
Grossman Adam S | Derivatives Exercise | 15,000 | 2025-08-15 | ||
Kestenberg-Messina Kaitlin M. | Sale | -1,208 | $18.59 | $22,457 | 2025-08-01 |
Kestenberg-Messina Kaitlin M. | Derivatives Exercise | 2,500 | 2025-08-01 | ||
Tade Brad L. | Sale | -7,123 | $17.31 | $123,299 | 2025-07-28 |
Kestenberg-Messina Kaitlin M. | Sale | -3,027 | $17.31 | $52,397 | 2025-07-28 |
Grossman Adam S | Sale | -21,000 | $18.66 | $391,860 | 2025-07-16 |
Grossman Adam S | Derivatives Exercise | 15,000 | 2025-07-16 | ||
Tade Brad L. | Sale | -9,838 | $18.4 | $181,019 | 2025-06-30 |
Grossman Adam S | Sale | -21,000 | $20.81 | $437,010 | 2025-06-18 |
Grossman Adam S | Derivatives Exercise | 15,000 | 2025-06-18 | ||
ELMS STEVE | Sale | -92,941 | $21.69 | $2,015,890 | 2025-06-16 |
ELMS STEVE | Sale | -332,680 | $20.82 | $6,926,398 | 2025-06-16 |
ELMS STEVE | Derivatives Exercise | 332,680 | 2025-06-16 | ||
Guiheen Lawrence P. | Sale | -20,000 | $20.96 | $419,200 | 2025-06-11 |
Grossman Jerrold B | Sale | -10,000 | $21.31 | $213,100 | 2025-06-10 |
Grossman Jerrold B | Derivatives Exercise | 10,000 | 2025-06-10 | ||
Guiheen Lawrence P. | Sale | -9,000 | $20.32 | $182,880 | 2025-05-23 |
Guiheen Lawrence P. | Derivatives Exercise | 9,000 | 2025-05-23 | ||
Grossman Adam S | Sale | -21,000 | $19.45 | $408,450 | 2025-05-16 |
Grossman Adam S | Derivatives Exercise | 15,000 | 2025-05-16 | ||
Grossman Adam S | Sale | -21,000 | $21.46 | $450,660 | 2025-04-16 |
Grossman Adam S | Derivatives Exercise | 15,000 | 2025-04-16 | ||
Kestenberg-Messina Kaitlin M. | Sale | -18,920 | $19.42 | $367,426 | 2025-04-02 |
Grossman Adam S | Sale | -21,000 | $18.92 | $397,320 | 2025-03-21 |
Grossman Adam S | Derivatives Exercise | 0 | 2025-03-21 | ||
Grossman Adam S | Sale | -85,951 | $16.91 | $1,453,431 | 2025-03-10 |
Kestenberg-Messina Kaitlin M. | Sale | -12,816 | $16.91 | $216,719 | 2025-03-10 |
Kestenberg-Messina Kaitlin M. | Sale | -1,855 | $15.44 | $28,641 | 2025-02-27 |
Grossman Adam S | Sale | -72,885 | $15.44 | $1,125,344 | 2025-02-27 |
Tade Brad L. | Sale | -5,280 | $15.78 | $83,318 | 2025-02-27 |
FINGER ALISON CECILY | Grant, award...etc | 10,889 | 2025-02-21 | ||
Grossman Jerrold B | Grant, award...etc | 10,889 | 2025-02-21 | ||
Tade Brad L. | Grant, award...etc | 62,227 | 2025-02-21 | ||
Grossman Adam S | Grant, award...etc | 252,022 | 2025-02-21 | ||
Kestenberg-Messina Kaitlin M. | Grant, award...etc | 77,784 | 2025-02-21 | ||
Salas Eduardo Rene | Grant, award...etc | 10,889 | 2025-02-21 | ||
KWON YOUNG | Grant, award...etc | -10,889 | 2025-02-21 | ||
ELMS STEVE | Grant, award...etc | 10,889 | 2025-02-21 | ||
Guiheen Lawrence P. | Grant, award...etc | 10,889 | 2025-02-21 | ||
Kestenberg-Messina Kaitlin M. | Sale | -3,355 | $16.1 | $54,016 | 2025-02-03 |
Kestenberg-Messina Kaitlin M. | Derivatives Exercise | 5,000 | 2025-02-03 | ||
Kestenberg-Messina Kaitlin M. | Sale | -1,854 | $17.15 | $31,796 | 2025-01-03 |
Grossman Adam S | Sale | -14,343 | $17.15 | $245,982 | 2025-01-03 |
ELMS STEVE | Derivatives Exercise | 9,000 | 2024-12-02 | ||
Grossman Adam S | Sale | -48,967 | $21.1 | $1,033,204 | 2024-11-22 |
Tade Brad L. | Sale | -15,000 | $21.15 | $317,250 | 2024-11-22 |
Grossman Adam S | Sale | -21,752 | $19.99 | $434,822 | 2024-10-02 |
Kestenberg-Messina Kaitlin M. | Sale | -2,647 | $19.99 | $52,914 | 2024-10-02 |
Guiheen Lawrence P. | Sale | -9,000 | $18.47 | $166,189 | 2024-09-11 |
Guiheen Lawrence P. | Derivatives Exercise | 0 | 2024-09-11 | ||
Grossman Jerrold B | Sale | -136,861 | $17.27 | $2,363,932 | 2024-08-30 |
Grossman Jerrold B | Derivatives Exercise | 0 | 2024-08-30 | ||
Kestenberg-Messina Kaitlin M. | Sale | -24,150 | $16.9 | $408,050 | 2024-08-30 |
Kestenberg-Messina Kaitlin M. | Derivatives Exercise | 0 | 2024-08-30 | ||
Grossman Adam S | Sale | -626,245 | $17.69 | $11,079,652 | 2024-08-27 |
Grossman Adam S | Derivatives Exercise | 0 | 2024-08-27 | ||
KWON YOUNG | Sale | -60,000 | $18.26 | $1,095,600 | 2024-08-27 |
Tade Brad L. | Grant, award...etc | 72,400 | 2024-07-26 | ||
Tade Brad L. | Initial | 2024-07-26 | |||
Kestenberg-Messina Kaitlin M. | Sale | -2,502 | $13.58 | $33,977 | 2024-07-26 |
Kestenberg-Messina Kaitlin M. | Sale | -2,085 | $11.18 | $23,310 | 2024-07-02 |
Grossman Adam S | Sale | -21,752 | $11.18 | $243,187 | 2024-07-02 |
Grossman Adam S | Sale | -100,000 | $10.72 | $1,071,980 | 2024-06-14 |
Grossman Adam S | Sale | -21,752 | $6.6 | $143,563 | 2024-04-02 |
Kestenberg-Messina Kaitlin M. | Initial | 2024-04-02 | |||
Kestenberg-Messina Kaitlin M. | Grant, award...etc | 192,320 | 2024-04-02 | ||
Kestenberg-Messina Kaitlin M. | Sale | -2,085 | $6.6 | $13,761 | 2024-04-02 |
ELMS STEVE | Sale | -461,716 | $6.01 | $2,774,913 | 2024-03-19 |
ELMS STEVE | Sale | -1,038,284 | $6.21 | $6,447,744 | 2024-03-15 |
Grossman Adam S | Sale | -83,766 | $6.12 | $512,648 | 2024-03-08 |
LENZ BRIAN | Sale | -33,642 | $6.12 | $205,889 | 2024-03-08 |
LENZ BRIAN | Sale | -4,935 | $5.36 | $26,452 | 2024-03-04 |
Grossman Adam S | Sale | -9,588 | $5.36 | $51,392 | 2024-03-04 |
Grossman Adam S | Grant, award...etc | 557,728 | 2024-02-28 | ||
FINGER ALISON CECILY | Grant, award...etc | 24,040 | 2024-02-28 | ||
Grossman Jerrold B | Grant, award...etc | 24,040 | 2024-02-28 | ||
KWON YOUNG | Grant, award...etc | 24,040 | 2024-02-28 | ||
Fong Bryant | Grant, award...etc | 24,040 | 2024-02-28 | ||
Guiheen Lawrence P. | Grant, award...etc | 24,040 | 2024-02-28 | ||
ELMS STEVE | Grant, award...etc | 24,040 | 2024-02-28 | ||
LENZ BRIAN | Sale | -8,257 | $5.26 | $43,432 | 2024-02-27 |
Grossman Adam S | Sale | -22,457 | $5.26 | $118,124 | 2024-02-27 |
Grossman Adam S | Sale | -23,057 | $4.52 | $104,218 | 2024-01-05 |
LENZ BRIAN | Sale | -16,908 | $4.52 | $76,424 | 2024-01-05 |
Grossman Adam S | Sale | -18,718 | $3.58 | $67,010 | 2023-10-03 |
LENZ BRIAN | Sale | -15,268 | $3.58 | $54,659 | 2023-10-03 |
Grossman Jerrold B | Open Market Purchase | 130,000 | $3.71 | 2023-08-30 | |
KWON YOUNG | Open Market Purchase | 25,000 | $3.9 | 2023-08-24 | |
Fong Bryant | Sale | -1,433,304 | $3.87 | $5,544,737 | 2023-08-23 |
Grossman Adam S | Sale | -250,000 | $4.15 | $1,038,350 | 2023-08-18 |
LENZ BRIAN | Derivatives Exercise | 809,262 | 2023-08-17 | ||
LENZ BRIAN | Sale | -1,020,840 | $4.6 | $4,693,312 | 2023-08-17 |
Grossman Adam S | Sale | -2,100,459 | $4.54 | $9,541,965 | 2023-08-17 |
Grossman Adam S | Derivatives Exercise | 0 | 2023-08-17 | ||
LENZ BRIAN | Sale | -15,268 | $3.69 | $56,339 | 2023-07-05 |
Grossman Adam S | Sale | -20,051 | $3.69 | $73,988 | 2023-07-05 |
Grossman Adam S | Sale | -17,853 | $3.31 | $59,093 | 2023-04-04 |
LENZ BRIAN | Sale | -15,469 | $3.31 | $51,202 | 2023-04-04 |
Grossman Jerrold B | Grant, award...etc | 25,815 | 2023-03-08 | ||
DEMSKI MARTHA J | Grant, award...etc | 25,815 | 2023-03-08 | ||
ELMS STEVE | Grant, award...etc | 25,815 | 2023-03-08 | ||
Guiheen Lawrence P. | Grant, award...etc | 25,815 | 2023-03-08 | ||
KWON YOUNG | Grant, award...etc | 25,815 | 2023-03-08 | ||
Fong Bryant | Grant, award...etc | 25,815 | 2023-03-08 | ||
Grossman Adam S | Grant, award...etc | 573,695 | 2023-03-08 | ||
Grossman Adam S | Sale | -49,544 | $3.42 | $169,440 | 2023-03-08 |
LENZ BRIAN | Grant, award...etc | 135,175 | 2023-03-08 | ||
LENZ BRIAN | Sale | -31,451 | $3.42 | $107,562 | 2023-03-08 |
The information provided in this report about ADMA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ADMA Biologics, Inc(NASDAQ:ADMA)


ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of pr...
Website: http://www.admabiologics.com
Founded: 2007
Full Time Employees: 313
CEO: Adam Grossman
Sector: Healthcare
Industry: Biotechnology